<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Reify Health — Prospect Detail</title>
  <link rel="stylesheet" href="styles.css">
</head>
<body>
<header class="site-header"><h1>Prospect Detail</h1></header>
<div class="container">
  <a href="index.html" class="back-link">&larr; Back to All Prospects</a>
  <div class="detail-header">
    <span class="badge health" style="font-size:.8rem;">Digital Health</span>
    <h1>61. Reify Health</h1>
    <p class="meta">Clinical Trial Management Platform</p>
  </div>
  <div class="section"><h3>1. Startup Name</h3><p><strong>Reify Health</strong></p></div>
  <div class="section"><h3>2. Founder Contact</h3><p><strong>Rock Health Boston Partners</strong></p><p>Harvard Medical School affiliated partners</p><p>Rock Health Boston accelerator cohort</p></div>
  <div class="section"><h3>3. Product Overview</h3><p>Reify Health is a clinical trial management platform accelerating drug development. The software helps pharmaceutical companies and research sites recruit patients, manage trial operations, and reduce the time and cost of bringing new drugs to market.</p></div>
  <div class="section"><h3>4. Funding Stage</h3><p><strong>Series D</strong> — Raised $220M+ from investors including Andreessen Horowitz.</p></div>
  <div class="section"><h3>5. How I Found the Company</h3><p>Discovered through Rock Health Boston portfolio and clinical trial innovation coverage.</p></div>
  <div class="strengths-weaknesses">
    <div class="section"><h3>Strengths</h3><ul><li><strong>Massive market:</strong> Clinical trial market exceeds $50B annually with major inefficiencies.</li><li><strong>Strong traction:</strong> Series D funding indicates significant customer adoption.</li></ul></div>
    <div class="section"><h3>Weaknesses</h3><ul><li><strong>Late-stage valuation:</strong> Significant funding may limit upside for new investors.</li><li><strong>Competitive market:</strong> Medidata, Veeva, and others compete in clinical trial software.</li></ul></div>
  </div>
  <div class="section"><h3>7. Five Questions for the Team</h3><ol class="questions-list"><li>How many clinical trials are currently running on your platform?</li><li>What is your average reduction in patient recruitment time?</li><li>How do you differentiate from Medidata and Veeva?</li><li>What therapeutic areas have the highest platform adoption?</li><li>What are your IPO or exit timeline considerations?</li></ol></div>
  <a href="index.html" class="back-link">&larr; Back to All Prospects</a>
</div>
</body>
</html>
